Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Portfolio Pulse from Avi Kapoor
Jim Cramer expressed his views on several stocks on CNBC's 'Mad Money Lightning Round.' He recommended buying Pfizer and First Solar, while labeling Moderna as a 'big disappointment.' Cramer also commented on Six Flags, Equity Residential, Vertiv Holdings, and Powell Industries, providing insights into their current market positions.
September 18, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cramer praises Equity Residential as an 'amazing' stock, with multiple analysts raising price targets.
Cramer's positive remarks and analyst upgrades suggest a bullish outlook for Equity Residential.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Cramer is bullish on First Solar, supported by BofA Securities' Buy rating and increased price target.
Cramer's positive sentiment and BofA's increased price target suggest a favorable outlook for First Solar.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Jim Cramer recommends buying Pfizer, supported by Cantor Fitzgerald's Overweight rating and a $45 price target.
Cramer's positive recommendation and Cantor Fitzgerald's Overweight rating with a $45 price target suggest a bullish outlook for Pfizer.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cramer recommends buying Powell Industries, which recently reported strong earnings.
Cramer's buy recommendation and strong earnings report suggest a positive outlook for Powell Industries.
CONFIDENCE 85
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Cramer sees Vertiv Holdings as a 'winner' on a pullback, with recent executive appointment.
Cramer's positive view and recent executive changes suggest potential upside for Vertiv Holdings.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
Cramer is not optimistic about Six Flags, describing its merger as problematic. JPMorgan lowered its price target.
Cramer's negative view and JPMorgan's reduced price target indicate potential downside for Six Flags.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Jim Cramer labels Moderna as a 'big disappointment' despite recent approval of its vaccine by Health Canada.
Cramer's negative sentiment towards Moderna, despite positive news, suggests potential short-term bearish impact.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70